Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Erica E. Weirich
Introduction
Erica E. Weirich is a notable inventor based in Redwood City, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in the rapid detection of infections in vulnerable patient populations.
Latest Patents
One of her key patents is titled "Rapid assay for infection in neonates." This innovative assay is designed for immunodeficient patients, such as neonates or those who are immunocompromised, including HIV or transplant patients. The method allows for diagnosis at the initial evaluation stage, which can help avoid unnecessary antibiotic treatment and confinement to intensive care units for uninfected patients. The assay is capable of detecting bacterial, viral, or fungal colonization in the bloodstream, cerebrospinal fluid (CSF), or urinary tract, making it particularly useful for diagnosing sepsis. The technique involves measuring polymorphonuclear leukocyte (PMN, neutrophil) CD11b levels using flow cytometry or laser scanning microscopy on low volume whole blood samples.
Career Highlights
Erica E. Weirich is affiliated with Leland Stanford Junior University, where she continues to advance her research and innovations. Her work has the potential to significantly improve patient outcomes in critical care settings.
Collaborations
She has collaborated with esteemed colleagues, including Ronald L. Rabin and Yvonne Maldonado, to further enhance the impact of her research.
Conclusion
Erica E. Weirich's contributions to medical diagnostics exemplify the importance of innovation in improving healthcare outcomes. Her work in developing rapid assays for infection detection is a testament to her dedication to advancing medical science.